Osaka, Japan

Eiji Ideue

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eiji Ideue: Innovator in Medicinal Chemistry

Introduction

Eiji Ideue is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating sleep-related disorders. With a total of 3 patents to his name, Ideue's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

One of Ideue's latest patents is focused on a cycloalkylurea derivative. This invention relates to a medicament designed for treating or preventing diseases associated with the orexin receptor, specifically the orexin type 2 receptor. The active ingredient in this medicament is a new compound featuring a urea structure or a pharmaceutically acceptable salt thereof. This innovative approach aims to address conditions such as narcolepsy, idiopathic hypersomnia, hypersomnia, and sleep apnea syndrome.

Career Highlights

Throughout his career, Eiji Ideue has worked with notable companies in the pharmaceutical industry, including Sumitomo Dainippon Pharma Co., Ltd. and Sumitomo Pharma Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and contribute to groundbreaking research.

Collaborations

Eiji Ideue has collaborated with several talented individuals in his field, including Masafumi Komiya and Shoukou Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Eiji Ideue's contributions to medicinal chemistry, particularly in the development of treatments for sleep disorders, highlight his role as an influential inventor. His work continues to pave the way for advancements in the pharmaceutical industry, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…